Cargando...
Neoadjuvant Paradigm for Accelerated Drug Development: An Ideal Model in Bladder Cancer
Neoadjuvant cisplatin-based combination chemotherapy for muscle-invasive bladder cancer (MIBC) has been shown to confer a survival advantage in two randomized clinical trials and a meta-analysis. Despite level 1 evidence supporting its benefit, utilization remains dismal with nearly one-half of pati...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AlphaMed Press
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755931/ https://ncbi.nlm.nih.gov/pubmed/23883869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0023 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|